PETS

PetMed Express, Inc.
CAPPED RATING

PetMed Express Inc is a nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications and other health products for dogs, cats, and horses direct to the consumer.

PetMed Express, Inc. (PETS) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Momentum (D). The rating has held at C for 14 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.2 / 5.0
C
Value
B-
Factor Score 3.0 / 5.0
Growth
D+
Factor Score 1.6 / 5.0
Profitability
C+
Factor Score 2.6 / 5.0
Momentum
D
Factor Score 1.2 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -31.3
EV / EBITDA -0.6
Rev Growth YoY -19.4%
Gross Margin 27.8%
Price Return 3M -46.3%
Price Return 12M -67.6%
Catalyst Signal 0.00
Market Cap $20.9M
TTM Revenue $160.3M
Price / Sales 0.1
ROE -90.8%

Historical Factor Score Progression

Held C for 14 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B- (3.0) D+ (1.6) C+ (2.6) D (1.2) C+ (2.6) C (2.2)
2026-11-07 B- (3.0) D+ (1.6) C+ (2.8) D (1.4) C+ (2.7) C (2.3)
2026-10-31 B- (3.0) D+ (1.6) C+ (2.8) D (1.3) C+ (2.7) C (2.3)
2026-10-24 B- (3.0) D+ (1.6) C+ (2.8) D (1.4) C+ (2.6) C (2.3)
2026-10-17 B- (3.0) D+ (1.6) C+ (2.8) D (1.4) C+ (2.6) C (2.3)
Page 1 of 6